KIF26B promotes bladder cancer progression via activating Wnt/beta-catenin signaling in a TRAF2-dependent pathway
In this study, we report that KIF26B is upregulated in bladder cancer and acts as an independent prognostic factor. Knockdown of kif26b blocks the proliferation, metastasis and cisplatin-resistance of bladder cancer cells.